Dr. Yingjuan Qian now serves as a Professor at the Nanjing Agricultural University. Dr. Yingjuan Qian received a Master's Degree in Preventive Veterinary Medicine from Nanjing Agricultural University in 2003 with a research paper on the generation of a recombinant fowl poxvirus expressing the gB epitope and also earned a Ph.D. from the University of Alabama at Birmingham, majoring in Cell Biology, with a focus on protein-dependent tumorigenesis in the p53 family in 2008. After that, Dr. Qian worked as a Postdoctoral Fellow at the University of California at Davis from 2008 to 2013. Since 2013, Dr. Qian has been employed as a Professor at the College of Veterinary Medicine of Nanjing Agricultural University, China. Dr. Qian’s research group is focused on virus/host interactions to understand herpesvirus pathogenesis, including MDV, PRV and BHV; development of diagnosis, antiviral agents, and vaccines for coronavirus, influenza, and emerging and reemerging viruses. Dr. Jung has published more than 20 research papers in well-known international journals and submitted four patents.
Dr. Yingjuan Qian now serves as a Professor at the Nanjing Agricultural University. Dr. Yingjuan Qian received a Master's Degree in Preventive Veterinary Medicine from Nanjing Agricultural University in 2003 with a research paper on the generation of a recombinant fowl poxvirus expressing the gB epitope and also earned a Ph.D. from the University of Alabama at Birmingham, majoring in Cell Biology, with a focus on protein-dependent tumorigenesis in the p53 family in 2008. After that, Dr. Qian worked as a Postdoctoral Fellow at the University of California at Davis from 2008 to 2013. Since 2013, Dr. Qian has been employed as a Professor at the College of Veterinary Medicine of Nanjing Agricultural University, China. Dr. Qian’s research group is focused on virus/host interactions to understand herpesvirus pathogenesis, including MDV, PRV and BHV; development of diagnosis, antiviral agents, and vaccines for coronavirus, influenza, and emerging and reemerging viruses. Dr. Jung has published more than 20 research papers in well-known international journals and submitted four patents.